Literature DB >> 2941745

[A new ELISA method for the diagnosis of toxoplasmosis. Assay of serum IgM by immunocapture with an anti-Toxoplasma gondii monoclonal antibody].

J Y Cesbron, A Caron, F Santoro, P Wattre, G Ovlaque, R J Pierce, J P Delagneau, A Capron.   

Abstract

The diagnosis of acute toxoplasmosis is based exclusively on the detection of IgM anti-Toxoplasma antibodies. The principal of the immunoenzymatic test reported here is the capture of serum IgM antibodies which are detected indirectly by the sequential addition of antigen and a monoclonal antibody directed against the immunodominant epitope at the surface of the tachyzoite. This test combines the sensitivity of enzyme-based assays and the specificity of monoclonal reagents and represents an important contribution to the diagnosis of Toxoplasma gondii infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2941745

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

1.  Bicentric evaluation of Access Toxo immunoglobulin M (IgM) and IgG assays and IMx toxo IgM and IgG assays and comparison with Platelia Toxo IgM and IgG assays.

Authors:  A Decoster; B Lecolier
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

2.  Advantage of using 35,000-molecular-weight protein for testing of Toxoplasma gondii immunoglobulin M.

Authors:  P Deletoille; G Ovlaque; B Slizewicz
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

3.  Platelia-Toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection of anti-P30 immunoglobulin A antibodies.

Authors:  A Decoster; B Slizewicz; J Simon; C Bazin; F Darcy; G Vittu; C Boulanger; Y Champeau; J L Demory; M Duhamel
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

4.  Anti-P30 IgA antibodies as prenatal markers of congenital toxoplasma infection.

Authors:  A Decoster; F Darcy; A Caron; D Vinatier; D Houze de L'Aulnoit; G Vittu; G Niel; F Heyer; B Lecolier; M Delcroix
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.